Showing results (291-300 of 436) with videos related to
Sort By:
Pageof 44
Gut Microbes|December 2, 2024
Defective Atg16l1 in intestinal epithelial cells links to altered fecal microbiota and metabolic shifts during pregnancy in miceVíctor A López-Agudelo, Maren Falk-Paulsen, Richa Bharti, et al.Immunity|November 4, 2006
SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoformsTakashi Nagaishi, Lily Pao, Sue-Hwa Lin, et al.Gut|February 27, 2025
Glucagon-like peptide-1 receptor agonist use is associated with a lower risk of major adverse liver-related outcomes: a meta-analysis of observational cohort studiesCiro Celsa, Grazia Pennisi, Adele Tulone, et al.Gut|September 8, 2017
NAD metabolism fuels human and mouse intestinal inflammationRomana R Gerner, Victoria Klepsch, Sophie Macheiner, et al.European Journal of Immunology|June 23, 2009
Role for hedgehog pathway in regulating growth and function of invariant NKT cellsWing-Kin Syn, Rafal P Witek, Stuart M Curbishley, et al.Wiener Klinische Wochenschrift|October 7, 2022
Bariatric surgery prevents carotid wall thickness progressionLukas Lunger, Andreas Melmer, Wolfgang Sturm, et al.Scientific Reports|August 20, 2016
Paternal chronic colitis causes epigenetic inheritance of susceptibility to colitisMarkus Tschurtschenthaler, Priyadarshini Kachroo, Femke-Anouska Heinsen, et al.Liver International : Official Journal of the International Association for the Study of the Liver|December 2, 2017
Ethanol-mediated suppression of IL-37 licenses alcoholic liver diseaseFelix Grabherr, Christoph Grander, Timon E Adolph, et al.Wiener Klinische Wochenschrift|December 3, 2016
Prescription of oral antidiabetic drugs in Tyrol - Data from the Tyrol diabetes registry 2012-2015Lukas Lunger, Andreas Melmer, Willi Oberaigner, et al.Journal of Translational Medicine|December 6, 2019
Microbiota, type 2 diabetes and non-alcoholic fatty liver disease: protocol of an observational studyBenedetta M Motta, Christoph Grander, Martin Gögele, et al.Pageof 44